AWW
ENZN

Alan W. Weber’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Alan W. Weber’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-210,111
Closed -$223K – 53
2015
Q1 		$223K Buy
+210,111
New +$217K 0.19% 42

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.26B AUM 15.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
Ativo Capital Management Chicago, Illinois $131M AUM 19.64% 1-Year Est. Return
SIM
Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Alan W. Weber's ENZN Position: Q2 2015 in Review

Alan W. Weber sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2015, closing a stake of 210,111 shares — an estimated $223K sold.

Alan W. Weber first reported a position in ENZN in Q1 2015 and held it in 1 quarter. The position peaked at $223K in Q1 2015. 58 funds tracked by Wall St. Rank hold ENZN as of Q2 2015.

  • Alan W. Weber reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2015 after selling out during the quarter.
  • Alan W. Weber sold 210,111 ENZON PHARMACEUTICALS INC shares in Q2 2015, an estimated $223K.
  • Alan W. Weber first reported a position in ENZON PHARMACEUTICALS INC in Q1 2015 and held it in 1 quarter.
  • Alan W. Weber's ENZON PHARMACEUTICALS INC position peaked at $223K in Q1 2015.
  • 58 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2015.

Based on Alan W. Weber's 13F filing for Q2 2015, filed 7 Aug 2015.